Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B.

导出 LinkOut

翻译打印收藏纠错

作者： Kelly L,Warfield ^[1] ; Kaitlyn R,Schaaf ^[2] ; Lisa Evans,DeWald ^[3] ; Kevin B,Spurgers ^[3] ; Wei,Wang ^[4] ; Eric,Stavale ^[5] ; Michelle,Mendenhall ^[6] ; Meghan H,Shilts ^[7] ; Timothy B,Stockwell ^[8] ; Dale L,Barnard ^[2] ; Urban,Ramstedt ^[4] ; Suman R,Das ^[4]

作者单位： Emergent BioSolutions, Gaithersburg, MD, 20879, USA. warfieldk@ebsi.com. ^[1] Department of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. ^[2] Emergent BioSolutions, Gaithersburg, MD, 20879, USA. ^[3] Infectious Diseases Group, J. Craig Venter Institute, Rockville, MD, 20852, USA. ^[4] Cellular Biology and Viral Immunology Section, DIR, National Institute of Health, Bethesda, MD, 20892, USA. ^[5] Integrated Biotherapeutics Inc., Gaithersburg, MD, 20878, USA. ^[6] Abviro, 4800 Hampden Lane, Bethesda, MD, 20814, USA. ^[7] Institute for Antiviral Research, Utah State University, Logan, UT, 84322-5600, USA. ^[8] National Biodefense Analysis and Countermeasures Center, 8300 Research Plaza, Fort Detrick, MD, 21702, USA. ^[9] Unither Virology, LLC, Silver Spring, MD, 20910, USA. ^[10] Department of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. suman.r.das@vanderbilt.edu. ^[11] Infectious Diseases Group, J. Craig Venter Institute, Rockville, MD, 20852, USA. suman.r.das@vanderbilt.edu. ^[12]